IIT Bombay Study Shows How TB Bacteria Shield Themselves from Antibiotics

New Delhi, December 3, 2025 – A groundbreaking study conducted by researchers at the Indian Institute of Technology (IIT) Bombay has revealed how the bacteria Mycobacterium tuberculosis, responsible for tuberculosis (TB), manage to survive antibiotic treatment and prolong their lifespan. This research sheds light on the mechanisms that enable these bacteria to evade the effects of antibiotics, even amidst effective treatment and vaccination campaigns.

The Global Burden of Tuberculosis

Despite advancements in medicine, tuberculosis remains a significant global health challenge. In 2024, approximately 10.7 million people were diagnosed with TB, leading to 1.23 million deaths worldwide. India bears a considerable burden, with over 2.71 million reported cases in the same year. The persistence of TB underscores the need for a deeper understanding of its causative agent and its resistance mechanisms.

Key Findings of the Study

The study, published in the journal Chemical Science, highlights that the bacteria’s ability to resist drugs is closely linked to their outer membrane, which is primarily composed of lipids (fats). The research team conducted experiments under two distinct conditions: an active phase, where the bacteria were rapidly dividing, and a dormant phase, which mimics the state seen in latent infections.

Experimental Conditions

• Active Phase: Bacteria were dividing rapidly, similar to an active infection.
• Dormant Phase: Conditions were created to mimic the dormancy of the bacteria, akin to latent TB infections.

Effects of Antibiotics

The researchers exposed the bacteria to four commonly used TB drugs: rifabutin, moxifloxacin, amikacin, and clarithromycin. They discovered that the concentration of these drugs required to inhibit 50% of bacterial growth was significantly higher in dormant bacteria compared to active ones. Specifically, the concentration needed was two to ten times greater for dormant bacteria.

Understanding Drug Resistance

Professor Shobhna Kapoor from the Department of Chemistry at IIT Bombay emphasized that the increased drug tolerance observed in dormant bacteria was not due to genetic mutations, which are typically associated with antibiotic resistance. Instead, the study found that the reduced sensitivity to drugs was likely linked to the bacteria’s dormant state and the structural characteristics of their membranes.

Role of Lipids in Bacterial Survival

The research team identified over 270 distinct lipid molecules present in the bacterial membranes, revealing notable differences between the active and dormant states. Active bacteria exhibited loose, fluid membranes, while dormant bacteria displayed rigid, tightly ordered structures. This rigidity serves as a defense mechanism against antibiotics.

Implications for Treatment

The study’s findings suggest that the outer membrane of dormant Mycobacterium tuberculosis acts as a formidable barrier to antibiotic penetration. For instance, rifabutin, an antibiotic, was found to easily enter active cells but struggled to penetrate the outer membrane of dormant cells. This discovery highlights the importance of the outer membrane as the bacteria’s primary line of defense against antibiotics.

Potential Solutions

Professor Kapoor proposed that if the outer membrane can be weakened, it may enhance the efficacy of existing antibiotics. This approach could potentially allow older drugs to regain effectiveness when combined with molecules that loosen the outer membrane. Such a strategy could make dormant bacteria more susceptible to treatment without providing them the opportunity to develop permanent resistance.

Conclusion

This study marks a significant advancement in our understanding of tuberculosis and its causative bacteria. By shifting the focus from proteins to lipids, researchers are uncovering new avenues for combating antibiotic resistance in TB. The findings not only deepen our understanding of bacterial survival mechanisms but also pave the way for innovative treatment strategies that could ultimately save lives.

Note: This article is based on a study conducted by IIT Bombay and reflects the ongoing research efforts in the field of tuberculosis and antibiotic resistance.